S. Begbie
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer
Papers in
- Oncology 2
- Cancer Treatment and Pharmacology 1
-
- Complementary and Alternative Medicine Studies 1
- Co-authors
- Pilar García Alfonso (1 shared paper)E.L. Levine (1 shared paper)Jean Alfred Maroun (1 shared paper)Werner Scheithauer (1 shared paper)Jim Cassidy (1 shared paper)Howard A. Burris (1 shared paper)Jerzy Załuski (1 shared paper)Chris J. Twelves (1 shared paper)
- Journals
- Nature Communications (1 paper)The Lancet Oncology (1 paper)Annals of Oncology (1 paper)The Breast (1 paper)Asia-Pacific Journal of Clinical Oncology (1 paper)
- Partner nations
- AustraliaUnited StatesPoland
In The Last Decade
S. Begbie
6 papers receiving 757 citations
S. Begbie's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 530
- Pathology and Forensic Medicine 131
- Complementary and alternative medicine 59
- Immunology 82
- Dermatology 30
Countries citing papers authored by S. Begbie
This map shows the geographic impact of S. Begbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Begbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Begbie more than expected).
Fields of papers citing papers by S. Begbie
This network shows the impact of papers produced by S. Begbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Begbie. The network helps show where S. Begbie may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Begbie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial Hit paper breakdown → | 2019 | 457 |
| 2 | 2003 | 233 | |
| 3 | 2008 | 79 | |
| 4 | 2024 | 12 | |
| 5 | 1996 | 7 | |
| 6 | 2009 | 1 |
About S. Begbie
S. Begbie is a scholar working on Oncology, Complementary and alternative medicine, Dermatology, Animal Science and Zoology and Cancer Research, having authored 6 papers that have together received 789 indexed citations. Recurring topics across this work include Biliary and Gastrointestinal Fistulas (1 paper), Complementary and Alternative Medicine Studies (1 paper), Breast Cancer Treatment Studies (1 paper), Foreign Body Medical Cases (1 paper), Phytochemistry Medicinal Plant Applications (1 paper), Cancer Treatment and Pharmacology (1 paper), Immune Cell Function and Interaction (1 paper) and Chemotherapy-related skin toxicity (1 paper). The work is most often cited by research in Oncology (530 citations), Pathology and Forensic Medicine (131 citations), Complementary and alternative medicine (59 citations), Immunology (82 citations) and Dermatology (30 citations). S. Begbie has collaborated with scholars based in Australia, United States and Poland. Frequent co-authors include Pilar García Alfonso, E.L. Levine, Jean Alfred Maroun, Werner Scheithauer, Jim Cassidy, Howard A. Burris, Jerzy Załuski, Chris J. Twelves, Alfred O. Wong and Guy A. Van Hazel. Their work appears in journals such as Nature Communications, The Lancet Oncology, Annals of Oncology, The Breast and Asia-Pacific Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.